Zinc Chloride

Zinc Chloride

SCHEMBL21296907

Cl[Zn]Cl.c1ccc2c(c1)OCO2

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.78
ITGB2 P05107 1/20 0.52
ICAM1 P05362 1/20 0.52
ITGAL P20701 1/20 0.52
PKM P14618 1/20 0.50
TSHR P16473 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.46
LMNA P02545 2/20 0.46
CRHBP P24387 2/20 0.46
CRHR2 Q13324 2/20 0.46
HTT P42858 2/20 0.46
CYP3A4 P08684 4/20 0.41
MAOB P27338 2/20 0.38
CYP2D6 P10635 2/20 0.37
CYP2C9 P11712 2/20 0.37
MAPK1 P28482 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP1A2 P05177 1/20 0.37
PTGS2 P35354 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4424499 0.88
SCHEMBL29353984 0.88
SCHEMBL8711 0.88
SCHEMBL14417491 0.88 ABCG2 (1.00) ABCG2ITGB2ICAM1ITGALPKM
Methane SCHEMBL23532210 0.85 ABCG2 (0.93) ABCG2ITGB2ICAM1ITGALPKM
Hydrochloric Acid SCHEMBL4243178 0.85 ABCG2 (0.93) ABCG2ITGB2ICAM1ITGALPKM
Hydrochloric Acid SCHEMBL21296905 0.82 ABCG2 (0.88) ABCG2ITGB2ICAM1ITGALPKM
SCHEMBL10518187 0.80 ABCG2 (0.82) ABCG2ITGB2ICAM1ITGALPKM
SCHEMBL7696302 0.79 ABCG2 (0.70) ABCG2ITGB2ICAM1ITGALPKM
Boric Acid SCHEMBL4621591 0.78 ABCG2 (0.78) ABCG2ITGB2ICAM1ITGALPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11389456-B2 Compounds and methods for treating oxalate-related diseases OXALURX, INC. (US) 2022-07-19 US disclosed
US-20200390778-A1 COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES OXALURX, INC. 2020-12-17 US disclosed
WO-2019165159-A1 COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES OXALURX, INC. (US) 2019-08-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200390778-A1 COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES XDH, PNPO, LOX ABCG2 1719/4885ITGB2 4136/4885ICAM1 4231/4885
US-11389456-B2 Compounds and methods for treating oxalate-related diseases XDH, PNPO, LOX ABCG2 1719/4885ITGB2 4136/4885ICAM1 4231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.